MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

J. Bousquet; S. Arnavielhe; A. Bedbrook; M. Bewick; D. Laune; E. Mathieu-Dupas; R. Murray; G. L Onorato; J. Pepin; R. Picard; F. Portejoie; E. Costa; J. Fonseca; O. Lourenço; M. Morais-Almeida; A. Todo-Bom; A. Cruz; J. da Silva; S. Serpa; M. Illario; E. Menditto; L. Cecchi; R. Monti; L. Napoli; M. Ventura; G. de Feo; D. Larenas-Linnemann; M. Fuentes Perez; R. Huerta Villabolos; D. Rivero-Yeverino; E. Rodriguez-Zagal; Flore Amat; Isabella Annesi-Maesano; I. Bosse; P. Demoly; P. Devillier; Julien Fontaine; J. Just; P. Kuna; B. Samolinski; A. Valiulis; R. Emuzyte; V. Kvedariene; D. Ryan; A. Sheikh; P. Schmidt-Grendelmeier; L. Klimek; O. Pfaar; K. Bergmann; R. Mösges; T. Zuberbier; E. Roller-Wirnsberger; P. Tomazic; J. Fokkens; N. Chavannes; S. Reitsma; J. Anto; V. Cardona; T. Dedeu; J. Mullol; T. Haahtela; J. Salimäki; S. Toppila-Salmi; E. Valovirta; B. Gemicioğlu; A. Yorgancioglu; N. Papadopoulos; E. Prokopakis; S. Bosnic-Anticevich; R. O’hehir; J. Ivancevich; H. Neffen; E. Zernotti; I. Kull; E. Melen; M. Wickman; C. Bachert; P. Hellings; S. Palkonen; C. Bindslev-Jensen; E. Eller; S. Waserman; M. Sova; G. de Vries; M. van Eerd; I. Agache; T. Casale; M. Dykewickz; R. N Naclerio; Y. Okamoto; D. Wallace

doi:10.1186/s13601-018-0227-6

Back

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Journal article

Open access

Peer reviewed

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

J. Bousquet, S. Arnavielhe, A. Bedbrook, M. Bewick, D. Laune, E. Mathieu-Dupas, R. Murray, G. L Onorato, J. Pepin, R. Picard, …

Clinical and Translational Allergy, Vol.8(1)

12/2018

DOI: https://doi.org/10.1186/s13601-018-0227-6

Abstract

Rhinitis

mHealth

ARIA

App

Asthma

Care pathways

MASK

mHealth, such as apps running on consumer smart devices is becoming increasingly popular and has the potential to profoundly affect healthcare and health outcomes. However, it may be disruptive and results achieved are not always reaching the goals. Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline using the best evidence-based approach to care pathways suited to real-life using mobile technology in allergic rhinitis (AR) and asthma multimorbidity. Patients largely use over-the-counter medications dispensed in pharmacies. Shared decision making centered around the patient and based on self-management should be the norm. Mobile Airways Sentinel networK (MASK), the Phase 3 ARIA initiative, is based on the freely available MASK app (the Allergy Diary, Android and iOS platforms). MASK is available in 16 languages and deployed in 23 countries. The present paper provides an overview of the methods used in MASK and the key results obtained to date. These include a novel phenotypic characterization of the patients, confirmation of the impact of allergic rhinitis on work productivity and treatment patterns in real life. Most patients appear to self-medicate, are often non-adherent and do not follow guidelines. Moreover, the Allergy Diary is able to distinguish between AR medications. The potential usefulness of MASK will be further explored by POLLAR (Impact of Air Pollution on Asthma and Rhinitis), a new Horizon 2020 project using the Allergy Diary.

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1186/s13601-018-0227-6View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence
Creators - without role: J. Bousquet - Forum
S. Arnavielhe - Kyomed
A. Bedbrook - Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon
M. Bewick - iQ4U consultants Ltd
D. Laune - Kyomed
E. Mathieu-Dupas - Kyomed
R. Murray - MedScript Ltd
G. L Onorato - Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon
J. Pepin - Université Grenoble Alpes
R. Picard - Conseil général de l'économie, de l'industrie et des technologies
F. Portejoie - Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon
E. Costa - Universidade do Porto
J. Fonseca - Centre for Health Technology and Services Research
O. Lourenço - University of Beira Interior
M. Morais-Almeida
A. Todo-Bom - Hospitais da Universidade de Coimbra
A. Cruz - Universidade Federal da Bahia
J. da Silva - Universidade Federal de Santa Catarina
S. Serpa
M. Illario - Regione Campania
E. Menditto - Federico II University Hospital
L. Cecchi - Azienda Usl Toscana Centro
R. Monti
L. Napoli
M. Ventura - University of Bari Aldo Moro
G. de Feo - University of Salerno
D. Larenas-Linnemann - Hospital Médica Sur
M. Fuentes Perez
R. Huerta Villabolos
D. Rivero-Yeverino
E. Rodriguez-Zagal
Flore Amat - Hôpital d'Enfants
Isabella Annesi-Maesano - Inserm
I. Bosse - CHU Montpellier = Montpellier University Hospital
P. Demoly - Centre Hospitalier Universitaire de Montpellier
P. Devillier - Hôpital Foch
Julien Fontaine - Institut d'Electronique du Solide et des Systèmes
J. Just - Hôpital d'Enfants
P. Kuna - Medical University of Lodz
B. Samolinski - Medical University of Warsaw
A. Valiulis - Vilnius University
R. Emuzyte - Vilnius University
V. Kvedariene - Vilnius University
D. Ryan - University of Edinburgh
A. Sheikh - University of Edinburgh
P. Schmidt-Grendelmeier - University Hospital of Zurich
L. Klimek - Zentrum für Rhinologie und Allergologie
O. Pfaar - Zentrum für Rhinologie und Allergologie
K. Bergmann - Charité - Universitätsmedizin Berlin
R. Mösges - University Hospital Cologne
T. Zuberbier - Charité - Universitätsmedizin Berlin
E. Roller-Wirnsberger
P. Tomazic - Medical University of Graz
J. Fokkens
N. Chavannes - Leiden University Medical Center
S. Reitsma - University of Amsterdam
J. Anto - Center for Research in Environmental Epidemiology
V. Cardona - Hebron University
T. Dedeu - Agència de Qualitat i Avaluació Sanitàries de Catalunya
J. Mullol - Hospital Clínic de Barcelona
T. Haahtela - Helsinki University Hospital
J. Salimäki
S. Toppila-Salmi - Helsinki University Hospital
E. Valovirta - University of Turku
B. Gemicioğlu - Istanbul University
A. Yorgancioglu
N. Papadopoulos - University of Manchester
E. Prokopakis - University of Crete
S. Bosnic-Anticevich - Woolcock Institute of Medical Research
R. O’hehir - Monash University
J. Ivancevich
H. Neffen
E. Zernotti - Universidad Católica de Córdoba
I. Kull - Karolinska Institutet
E. Melen - Sachs' Children and Youth Hospital
M. Wickman - Center for Clinical Research Dalarna
C. Bachert - Ghent University Hospital
P. Hellings - KU Leuven
S. Palkonen - European Federation of Allergy and Airways Diseases Patients Associations
C. Bindslev-Jensen - Odense University Hospital
E. Eller - Odense University Hospital
S. Waserman - McMaster University
M. Sova - University Hospital Olomouc
G. de Vries
M. van Eerd
I. Agache - Transylvania University of Brașov
T. Casale - University of South Florida
M. Dykewickz - Saint Louis University
R. N Naclerio - Johns Hopkins Medicine
Y. Okamoto - Chiba University Hospital
D. Wallace - Nova Southeastern University
Publication Details: Clinical and Translational Allergy, Vol.8(1)
Identifiers: 9933821909311
Academic Unit: Université de Montpellier
Language: English
Resource Type: Journal article
Local Fields: hal-02099394